When your own investors start publicly questioning your valuation, that's not a red flag - that's a five-alarm fire. And that's exactly what's happening at OpenAI, where the $852 billion price tag from last month's fundraising round is drawing skepticism from the very people who just wrote the checks.
According to a Financial Times report, some OpenAI backers are expressing concerns that the company has redrawn its product roadmap twice in the past six months, first pivoting to compete with Google and then scrambling to counter Anthropic. For a company that just raised $122 billion - likely the largest fundraising round in Silicon Valley history - that kind of strategic whiplash is not what investors signed up for.
Here's the quote that should terrify anyone who bought into the hype: "You have ChatGPT, a 1 billion-user business growing 50-100% a year, what are you doing talking about enterprise and code? It's a deeply unfocused company." That's from an early OpenAI backer, speaking to the FT. When insiders are calling you unfocused after you raise $122 billion, that's not constructive criticism - that's buyers' remorse.
Let's talk about what's really going on here. OpenAI has ChatGPT, which is legitimately huge - a billion users, insane growth, and consumer mind-share that most companies would kill for. But instead of doubling down on what's working, they keep chasing whatever competitor is making headlines. Google releases something? Pivot. Anthropic gets traction? Pivot again. That's not strategy, that's panic.
The concern from investors isn't just about focus, it's about the numbers. Some are predicting that Anthropic's revenue growth will overtake OpenAI's within a couple of months. If true, that's a disaster for an $852 billion valuation. You don't get to be worth nearly a trillion dollars by getting outgrown by your main competitor. That's the kind of thing that makes bankers start quietly updating their IPO models.
And speaking of that IPO - OpenAI is reportedly eyeing a public offering as early as this year. Which means all of this drama is happening right before they try to sell shares to the public. If your own investors are leaking concerns to the Financial Times months before your IPO, that's not an accident. That's either a warning shot to management or investors trying to reset expectations before the roadshow.


